Y-mAbs Therapeutics Inc.

NASDAQ: YMAB · Real-Time Price · USD
4.42
-0.09 (-2.00%)
At close: Jul 01, 2025, 3:59 PM
4.41
-0.23%
After-hours: Jul 01, 2025, 04:04 PM EDT

Y-mAbs Therapeutics Revenue

Y-mAbs Therapeutics reported an annual revenue of $87.69M, reflecting a 3.38% growth. For the quarter ending March 31, 2025, Y-mAbs Therapeutics generated $20.9M in revenue.
Revenue (ttm)
$87.69M
Revenue Growth
3.38%
Price / Sales Ratio
3.96
Revenue / Employee
$843.13K
Employees
104
Market Cap
200.21M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.